Concepedia

A phase II study of S-1 in patients with metastatic breast cancer — A Japanese trial by the S-1 cooperative study group, breast cancer working group

Toshiaki Saeki, Shigemitsu Takashima, Muneaki Sano, N Horikoshi, Shigeto Miura, Satoru Shimizu, Ken Morimoto, Morihiko Kimura, Hideaki Aoyama, Jun Ota,

Breast Cancer · 2004 · 82 citations · 28 references

DOI

Concepts

References

28

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

Masanori Miwa, Masako Ura, M Nishida et al. · European Journal of Cancer · 1998 · 1.2K citations

, , +12

Patient preferences for oral versus intravenous palliative chemotherapy.

Geoffrey Liu, E. Franssen, Margaret I. Fitch et al. · Journal of Clinical Oncology · 1997 · 920 citations

, , +14

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1999 · 791 citations

, , +16

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Yuh Sakata, Atsushi Ohtsu, N Horikoshi et al. · European Journal of Cancer · 1998 · 564 citations

, , +11